Literature DB >> 12406547

Role of the progesterone receptor (PR) in susceptibility of mouse mammary gland to 7,12-dimethylbenz[a]anthracene-induced hormone-independent preneoplastic lesions in vitro.

Robert T Chatterton1, John P Lydon, Rajendra G Mehta, Esnar T Mateo, Ashley Pletz, V Craig Jordan.   

Abstract

Glands of wild-type (WT) and progesterone receptor knockout (PRKO) mice were exposed to 7,12-dimethylbenz[a]anthracene (DMBA) while cultured in serum-free medium containing insulin, prolactin, aldosterone, and cortisol. Glands of WT but not PRKO mice responded to DMBA with epithelial hyperplasia after 10 days in this medium. After culture without prolactin and adrenocortical hormones for an additional 14 days, hyperplastic lesions were present only in glands of WT mice. We conclude that in the absence of PR, epithelial structures are resistant to the carcinogenic action of DMBA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406547     DOI: 10.1016/s0304-3835(02)00461-5

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

Review 1.  Progesterone receptors in mammary gland development and tumorigenesis.

Authors:  Orla M Conneely; Biserka M Jericevic; John P Lydon
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

2.  Finally! A model for progesterone receptor action in normal human breast.

Authors:  John P Lydon; Dean P Edwards
Journal:  Endocrinology       Date:  2009-07       Impact factor: 4.736

3.  Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.

Authors:  Nicole C Clark; Anne M Friel; Cindy A Pru; Ling Zhang; Toshi Shioda; Bo R Rueda; John J Peluso; James K Pru
Journal:  Cancer Biol Ther       Date:  2016-01-19       Impact factor: 4.742

Review 4.  From the ranks of mammary progesterone mediators, RANKL takes the spotlight.

Authors:  Rodrigo Fernandez-Valdivia; John P Lydon
Journal:  Mol Cell Endocrinol       Date:  2011-09-22       Impact factor: 4.102

5.  Role of ERalpha in the differential response of Stat5a loss in susceptibility to mammary preneoplasia and DMBA-induced carcinogenesis.

Authors:  Anne M Miermont; Angela R Parrish; Priscilla A Furth
Journal:  Carcinogenesis       Date:  2010-02-24       Impact factor: 4.944

Review 6.  The biology of progesterone receptor in the normal mammary gland and in breast cancer.

Authors:  Alison E Obr; Dean P Edwards
Journal:  Mol Cell Endocrinol       Date:  2011-12-13       Impact factor: 4.102

Review 7.  Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.

Authors:  J Julie Kim; Takeshi Kurita; Serdar E Bulun
Journal:  Endocr Rev       Date:  2013-01-09       Impact factor: 19.871

8.  Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.

Authors:  Anita K Bakrania; Bhavesh C Variya; Snehal S Patel
Journal:  Front Pharmacol       Date:  2017-12-19       Impact factor: 5.810

9.  Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cells.

Authors:  Anastasia Kougioumtzi; Panayiotis Tsaparas; Angeliki Magklara
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.